Royals’ Miguel Tejada Reportedly Connected to Biogenesis Investigation
Jason Miller/Getty Images
Miguel Tejada, who was recently suspended 105 games for testing positive for amphetamines, has reportedly also been linked to the Biogenesis investigation.
ESPN’s Pedro Gomez has the news:
Kansas City Royals infielder Miguel Tejada, suspended for 105 games last week because of positive tests for amphetamine use this season, was also implicated in the Biogenesis investigation, sources familiar with the case confirmed to ESPN.
Major League Baseball’s investigation into Tony Bosch and Biogenesis for his clinic’s role in supplying performance-enhancing drugs resulted in the suspension of 13 players, including other former MVPs Ryan Braun and Alex Rodriguez, with the latter currently appealing his 211-game punishment.
According to Gomez, Bosch supplied evidence that he had also served Tejada.
However, the Kansas City Royals shortstop was reportedly given a choice by the league to either accept his 105-game suspension—he tested positive three times previously for amphetamines, with the second resulting in a 25-game suspension and the third resulting in 80 games—or receive a steeper punishment for his involvement in the Biogenesis scandal.
He chose the 105-game suspension, which will keep him out of a large portion of the 2014 MLB season.
Tejada, who won the American League MVP in 2002 and established himself as an elite power-hitting shortstop in the 2000s with the Oakland Athletics and Baltimore Orioles, was playing for the Royals after spending 2012 with the Norfolk Tides, the Orioles’ Triple-A affiliate.
In 53 games with Kansas City, he was hitting .288/.317/.378 with three home runs, 20 RBI and 15 runs scored.
By the time he is eligible to return, Tejada will be 40 years old and a free agent, so it’s very possible that we have seen the last of the former MVP on an MLB field.
SD Yankee Report 